The global patient registry software market value was USD 1.10 Billion in 2019, which is expected to reach USD 2.96 Billion by 2027, and register a CAGR of 13.9% during the forecast period. The global patient registry software market revenue is expected to expand significantly during the forecast period owing to growing demand for advanced and specialized care in developed and developing economies across the globe.
The latest industry intelligence report on the Patient Registry Software Market performs a cautious examination of the current business environment and competitive landscape of the Patient Registry Software Market for the forecast period, 2020 - 2027. For stakeholders, field marketing executives and product owners planning to maintain a competitive edge the market assessment report brings to light essential impression about the growth rate, share and size of the industry during the estimated period. Deep dive into an array of elements including but not limited to the value proposition, product positioning, and targeting and industry segmentation have been described through resources such as charts, tables, and info graphics.
Read more@ https://www.emergenresearch.com/industry-report/patient-registry-so...
Competitive Landscape
IQVIA Holdings, Inc.
ImageTrend, Inc.
McKesson Corporation
Optum, Inc.
International Business Machines Corporation
Syneos Health Inc.
Premier, Inc.
Phytel, Inc.
Telligen, Inc.
Dacima Software Inc.
You Can Download Free Sample PDF Copy of Patient Registry Software Market at https://www.emergenresearch.com/request-sample/465
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkedIn | Twitter | Blogs